Tilray Brands (TLRY) Revenue Growth (1y) (2018 - 2026)
Tilray Brands (TLRY) Revenue Growth (1y) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.06 Bn | 87.19 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.81 Bn | 32.07 Bn | 1.97 Bn | 2.34% |
| 3 | Zoetis | 32.50 Bn | 30.56 Bn | 1.62 Bn | 2.91% |
| 4 | Takeda Pharmaceutical | 27.51 Bn | 23.45 Bn | 4.39 Bn | -11.85% |
| 5 | United Therapeutics | 23.19 Bn | 21.04 Bn | 648.10 Mn | -1.62% |
| 6 | RedHill Biopharma | 21.76 Bn | 21.76 Bn | - | - |
| 7 | Viatris | 20.28 Bn | 18.47 Bn | 1.16 Bn | 7.85% |
| 8 | Neurocrine Biosciences | 17.72 Bn | 16.40 Bn | 800.70 Mn | 42.25% |
| 9 | Elanco Animal Health | 12.56 Bn | 12.13 Bn | 785.00 Mn | 14.92% |
| 10 | Tilray Brands | 445.07 Mn | 384.87 Mn | 54.95 Mn | 11.28% |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | 11.28% |
| Nov 30, 2025 | 3.11% |
| Aug 31, 2025 | 4.73% |
| May 31, 2025 | -2.33% |
| Feb 28, 2025 | -1.36% |
| Nov 30, 2024 | 8.87% |
| Aug 31, 2024 | 13.05% |
| May 31, 2024 | 24.81% |
| Feb 29, 2024 | 29.36% |
| Nov 30, 2023 | 34.44% |
| Aug 31, 2023 | 15.49% |
| May 31, 2023 | 20.13% |
| Feb 28, 2023 | -4.14% |
| Nov 30, 2022 | -7.10% |
| Aug 31, 2022 | -8.82% |
| May 31, 2022 | 7.80% |
| Feb 28, 2022 | 22.58% |
| Nov 30, 2021 | 19.85% |
| Aug 31, 2021 | 43.01% |
| May 31, 2021 | 25.27% |